| 000 | 01688 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517104523.0 | ||
| 264 | 0 | _c20171017 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1472-6963 | ||
| 024 | 7 |
_a10.1186/s12913-016-1482-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLewis, A | |
| 245 | 0 | 0 |
_aThe economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries. _h[electronic resource] |
| 260 |
_bBMC health services research _c07 2016 |
||
| 300 |
_a251 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBudesonide _xadministration & dosage |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDry Powder Inhalers |
| 650 | 0 | 4 |
_aEthanolamines _xadministration & dosage |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFormoterol Fumarate |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aReceptors, Glucocorticoid |
| 700 | 1 | _aTorvinen, S | |
| 700 | 1 | _aDekhuijzen, P N R | |
| 700 | 1 | _aChrystyn, H | |
| 700 | 1 | _aWatson, A T | |
| 700 | 1 | _aBlackney, M | |
| 700 | 1 | _aPlich, A | |
| 773 | 0 |
_tBMC health services research _gvol. 16 _gp. 251 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12913-016-1482-7 _zAvailable from publisher's website |
| 999 |
_c26217743 _d26217743 |
||